Pre Tax Profit Cambiamento Data
AbbVie USD 5.99B 243M 2023-12
Abbott USD 2.44B 110M 2023-12
Amgen USD 3.03B 153M 2023-12
Baxter International USD 568M 124M 2023-12
Biogen USD 801.7M 231.6M 2023-06
Bristol-Myers Squibb USD 4.07B 613M 2023-12
Catalent USD -30000000 9M 2023-12
Eli Lilly USD 2.59B 2.27B 2023-12
Endo International USD 5.65M 152.91M 2022-06
Gilead Sciences USD 2.59B 586M 2023-12
GlaxoSmithKline GBP 2.62B 600M 2023-09
J&J USD 6.24B 1.8B 2023-12
Medtronic USD 2.01B 106M 2023-09
Merck USD -473000000 6.86B 2023-12
Neurocrine Biosciences USD 198.2M 82.6M 2023-12
Perrigo USD 107.6M 14.1M 2023-09
Pfizer USD -1250000000 5.38B 2023-09
Prestige Brands USD 69.58M 845K 2023-12
Regeneron Pharmaceuticals USD 1.4B 54.4M 2023-12
Revance Therapeutics USD -140876000 73.56M 2023-09
Roche Holding CHF 10.33B 1.48B 2023-06
Sanofi EUR 3.96B 1.2B 2023-09
United Therapeutics USD 295.4M 56.4M 2023-12
Zoetis USD 698M 84M 2023-12



Eli Lilly L'Utile Ante Imposte - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2024.